Feridex I.V.®

Feridex I.V.® (generic name: ferumoxides) is AMAG Pharmaceuticals' contrast agent for use with magnetic resonance imaging (MRI) for the detection of liver lesions. Several types of cancer can spread to the liver. The ability to identify metastatic tumors in the liver plays a key role in staging patients and determining appropriate patient management.

Diagnosis of metastases in the liver at an early stage can be difficult because small tumors are frequently not accompanied by detectable physical symptoms. We believe that contrast–enhanced MRI exams using Feridex I.V.® enable the imaging of liver lesions that may not be visible with other modalities used for liver imaging.

Feridex is marketed in the United States by Bayer Healthcare Pharmaceuticals, in Europe by Guerbet S.A. and in South Korea by TaeJoon. If you have questions or would like product information about Feridex I.V. in the U.S., please contact Bayer Healthcare Pharmaceuticals at 1-877-BAYER50.

Download the Feridex I.V.® Package Insert